Investors

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Latest News


Race Oncology EMD AML Trial Featured on NBN News

Race Oncology Investor Briefing – Melbourne 20th Oct 2022

September 2022 Quarterly Activity Report & Appendix 4C

Pitt St Research interview with Race Oncology’s CEO Phil Lynch & CSO Dr Daniel Tillett

Pitt Street Research Initiates Coverage of Race Oncology

Race Oncology Limited (ASX:RAC) is an Australian pharmaceutical company focused on the development o…